# Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pazopanib-based-oral-metronomic-therapy-for-platinum-resistant-refractory/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Aparna Sharma,Mayank Singh,Ravi Chauhan,Prabhat Singh Malik,Sachin Khurana,Sandeep Mathur,Sunesh Kumar,Vishnubhatla Sreenivas,Lalit Kumar |
| Citations | 23 |
| DOI | 10.1016/j.ygyno.2021.05.025 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3164992420 |
| PMID | 34088513 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Sachin Khurana](https://scholariq.org/researchers/sachin-khurana/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.